| A review of gliptins in 2011. | |
| | |
MedLine Citation:
|
PMID: 22149369 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Introduction: Dipeptidylpeptidase-4 (DPP-4) inhibitors offer new options for the management of type 2 diabetes (T2DM). Areas covered: This paper is an updated review, providing an analysis of both the similarities and the differences between the various compounds known as gliptins, currently used in the clinic (sitagliptin, vildagliptin, saxagliptin, alogliptin and linagliptin). This paper discusses the pharmacokinetic and pharmacodynamic characteristics of gliptins; both the efficacy and safety profiles of gliptins in clinical trials (compared with classical glucose-lowering agents), given as monotherapy or in combination, including in special populations; the positioning of DPP-4 inhibitors in the management of T2DM in recent guidelines; and various unanswered questions and perspectives. Expert opinion: The role of DPP-4 inhibitors in the therapeutic armamentarium of T2DM is evolving, as their potential strengths and weaknesses become better defined. Future critical issues may include the durability of glucose control, resulting from better β-cell protection, positive effects on cardiovascular outcomes and long-term safety issues. |
| | |
Authors:
|
André J Scheen |
Related Documents
:
|
22022539 - Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of di... 8260199 - Could non-insulin-dependent diabetes mellitus be attributable to a deficiency of fad-li... 2775859 - The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic... 21358699 - Need for better diabetes treatment for improved renal outcome. 22262069 - Incretin therapy - present and future. 1397349 - In situ saphenous vein bypass surgery in diabetic patients. 14739909 - Alcohol consumption, homeostasis model assessment indices and blood pressure in middle-... 11268029 - Correlation between nerve conduction studies and clinical scores in diabetic neuropathy. 18630389 - Diabetes and alcohol: distinctive interactions. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: 13 ISSN: 1744-7666 ISO Abbreviation: Expert Opin Pharmacother Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2011-12-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: England |
Other Details:
|
Languages: eng Pagination: 81-99 Citation Subset: IM |
Affiliation:
|
University of Liège, Division of Diabetes, Nutrition and Metabolic Disorders, and Division of Clinical Pharmacology, Department of Medicine , CHU Sart Tilman (B35), B-4000 LIEGE 1 , Belgium +32 4 3667238 ; +32 4 3667068 ; andre.scheen @ chu.ulg.ac.be. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.
Next Document: Linagliptin , a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy...